Cheng R Z, Murano S, Kurz B, Shmookler Reis R J
Department of Medicine, University of Arkansas for Medical Sciences, Little Rock.
Mutat Res. 1990 Sep-Nov;237(5-6):259-69. doi: 10.1016/0921-8734(90)90008-f.
Werner syndrome (WS) is a recessive genetic condition associated with markedly reduced replicative lifespans of cells in culture, high chromosomal instability in vivo and in vitro, and premature appearance of many characteristics of normal aging, including an increased incidence of cancer. We have monitored plasmid homologous recombination frequencies in diploid fibroblasts from 6 Werner or Werner-like syndrome patients, following transfection with a plasmid substrate containing 2 overlapping fragments of the TN5 Neor gene. Plasmid DNA recovered from these cells was then assayed for homologous recombination by (a) transformation of recA- bacteria to Ampr (indicating total viable plasmid) or Neor (indicating viable recombinant plasmid), and (b) by limited-cycle polymerase chain reaction (PCR) to co-amplify a recombinant fragment containing the overlap region, and a control region of the same plasmid, without bacterial transformation. Bacterial assay data indicated that recombination rates in 3 of the 6 WS strains were significantly elevated above normal controls; 4 of 6 appeared elevated by PCR assay. The highest-recombination WS strain showed evidence of reduced degradation of transfected plasmid DNA. For this small sample of WS strains, clinical severity of WS was not well correlated with recombination rate as determined by either assay (Pearson r = 0.78, not significant, for PCR assay); elevated recombination may, however, define a subset of WS at greatest risk for cancer and/or atherosclerosis. PCR assay of a hyperoxia-resistant HeLa cell line, displaying substantially increased chromosome breakage, indicated increased recombination between direct-repeat fragments. Nevertheless, elevated recombination in WS strains is unlikely to be secondary to impaired replicative capacity characteristic of WS cells, or to defective repair of chromosome damage which is increased in WS, since recombination in non-WS strains was unaffected by passage level or repeated UV irradiation.
沃纳综合征(WS)是一种隐性遗传疾病,其与培养细胞的复制寿命显著缩短、体内和体外的高染色体不稳定性以及许多正常衰老特征的过早出现有关,包括癌症发病率增加。在用含有TN5新霉素基因的2个重叠片段的质粒底物转染后,我们监测了6名沃纳或沃纳样综合征患者的二倍体成纤维细胞中的质粒同源重组频率。然后,通过以下方法对从这些细胞中回收的质粒DNA进行同源重组检测:(a)将recA-细菌转化为氨苄青霉素抗性(表明总存活质粒)或新霉素抗性(表明存活重组质粒),以及(b)通过有限循环聚合酶链反应(PCR)共扩增包含重叠区域的重组片段和同一质粒的对照区域,无需细菌转化。细菌检测数据表明,6个WS菌株中的3个的重组率显著高于正常对照;通过PCR检测,6个中有4个似乎升高。重组率最高的WS菌株显示出转染质粒DNA降解减少的证据。对于这个小样本的WS菌株,WS的临床严重程度与通过任何一种检测方法确定的重组率均无良好相关性(PCR检测的皮尔逊r = 0.78,不显著);然而,重组率升高可能定义了患癌症和/或动脉粥样硬化风险最大的WS亚组。对显示染色体断裂大幅增加的耐高氧HeLa细胞系进行PCR检测,表明直接重复片段之间的重组增加。然而,WS菌株中重组率升高不太可能继发于WS细胞特有的复制能力受损,或继发于WS中增加了的染色体损伤的缺陷修复,因为非WS菌株中的重组不受传代水平或重复紫外线照射的影响。